- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01742806
Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer
Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer: Multicenter Prospective Randomized Comparison Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We investigate the effect on drainage amount of Bio-absorbable Felt(NEOVEIL®) after D1+b or D2 lymphadenectomy with distal gastrectomy for early gastric cancer.
This study is an randomised controlled trial undertaken in 7 centers in South Korea. Patients with stage I-II gastric cancer who is going to have curative distal gastrectomy with D1+b or D2 lymphadenectomy are randomly assigned to use bio-absorbable felt(NEOVEIL®) or not to use it. Block randomisation will be done by a central interactive computerised system, stratified by center.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bucheon, Korea, Republic of
- Recruiting
- Soonchunhyang University College of Medicine, Bucheon Hospital
-
Contact:
- Gyu Seok Cho, M.D., Ph.D.
-
Principal Investigator:
- Gyu Seok Cho, M.D., Ph.D.
-
Busan, Korea, Republic of
- Recruiting
- Dong-A University College of Medicine
-
Contact:
- Min-Chan Kim, M.D., Ph.D.
-
Principal Investigator:
- Min-chan Kim, M.D., Ph.D.
-
Seoul, Korea, Republic of
- Recruiting
- Yonsei University Health System, Severance Hospital
-
Contact:
- WOO JIN HYUNG, M.D., Ph.D.
- Email: wjhyung@yuhs.ac
-
Principal Investigator:
- Woo Jin Hyung, M.D., Ph.D.
-
Seoul, Korea, Republic of
- Not yet recruiting
- Seoul National University College of Medicine, Seoul National University Hospital
-
Contact:
- Hyuk-Joon Lee, M.D., Ph.D.
-
Principal Investigator:
- Hyuk-Joon Lee, M.D.,Ph.D.
-
Seoul, Korea, Republic of
- Recruiting
- The Catholic University of Korea, Yeouido St. Mary's Hospital
-
Contact:
- WOOK KIM, M.D. Ph.D.
-
Principal Investigator:
- WOOK KIM, M.D., Ph.D.
-
-
Gyenggi-do
-
Seongnam-si, Gyenggi-do, Korea, Republic of
- Recruiting
- Seoul National University College of Medicine, Bundang Hospital
-
Contact:
- Hyung-Ho Kim, M.D., Ph.D.
-
Principal Investigator:
- Hyung-Ho Kim, M.D., Ph.D.
-
-
Gyeonggi-do
-
Suwon, Gyeonggi-do, Korea, Republic of
- Recruiting
- Ajou University Medical Center
-
Principal Investigator:
- Sang-Uk Han, M.D., Ph.D.
-
Contact:
- Sang-Uk Han, M.D., Ph.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- histologic confirmed gastric adenocarcinoma
- Patients who underwent laparoscopic distal gastrectomy.
- preoperative clinical stage I diagnosed with esophagogastroduodenoscopy,endoscopic ultrasonography and computerized tomography.
- patients who underwent more than D1+b lymphadenectomy
Exclusion Criteria:
- Vulnerable participants (pregnant women, under 20 year old, and so on)
- liver or renal disease (Ex. liver cirrhosis, end stage renal disease)
- Transfusion is needed preoperatively or postoperatively due to bleeding
- Preoperative or intraoperative evaluation confirm ascites.
- Patients who use anticoagulant preoperatively or postoperatively
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control
not to use bio-absorbable felt(NEOVEIL®)
|
|
Experimental: NEOVEIL®
To use bio-absorbable felt
|
To cover bio-absorbable felt over the lymphadenectomy area (hepatoduodenal ligament, #5 and 12/gastroduodenal artery, #6/ pancreas head /suprapancreatic area, #7,8 and 9)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to drain removal
Time Frame: two weeks
|
Daily amount of exudate is less than 100cc during consecutive 2 days.
There is no evidence of anastomotic leakage, intra-abdominal abscess or bleeding.
|
two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
total amount of exudate drainage
Time Frame: two weeks
|
Total amount of exudate after surgery is recorded.
|
two weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to discharge after surgery and postoperative complication
Time Frame: up to 30days after randomization
|
Time to discharge after surgery and postoperative complication are recorded
|
up to 30days after randomization
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: WOO JIN HYUNG, M.D. Ph.D., Yonsei University
Publications and helpful links
General Publications
- Nakamura T, Shimizu Y, Watanabe S, Hitomi S, Kitano M, Tamada J, Matsunobe S. New bioabsorbable pledgets and non-woven fabrics made from polyglycolide (PGA) for pulmonary surgery: clinical experience. Thorac Cardiovasc Surg. 1990 Apr;38(2):81-5. doi: 10.1055/s-2007-1013999.
- Hayashibe A, Sakamoto K, Shinbo M, Makimoto S, Nakamoto T. New method for prevention of bile leakage after hepatic resection. J Surg Oncol. 2006 Jul 1;94(1):57-60. doi: 10.1002/jso.20548.
- Ueda K, Tanaka T, Li TS, Tanaka N, Hamano K. Sutureless pneumostasis using bioabsorbable mesh and glue during major lung resection for cancer: who are the best candidates? J Thorac Cardiovasc Surg. 2010 Mar;139(3):600-5. doi: 10.1016/j.jtcvs.2009.06.021. Epub 2009 Aug 4.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-2012-0017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Cancer
-
City of Hope Medical CenterRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage 0 Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric Cancer AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage IB Gastric Cancer AJCC v8 | Pathologic Stage II Gastric Cancer AJCC v8 | Pathologic... and other conditionsUnited States
-
City of Hope Medical CenterActive, not recruitingAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedGastric Adenocarcinoma | Stage IV Gastric Cancer | Stage II Gastric Cancer | Stage III Gastric CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Gastric Cardia Adenocarcinoma | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage IIIB Gastric Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric CancerUnited States
-
National Cancer Institute (NCI)CompletedGastric Cancer | Gastric NeoplasmsUnited States
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma Gastric | Metastatic Gastric Cancer | GastroEsophageal Cancer | HER2 Positive Gastric CancerGermany
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Epstein-Barr Virus Positive | Mismatch Repair Protein Deficiency | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage III Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage... and other conditionsUnited States
Clinical Trials on bio-absorbable felt(NEOVEIL®)
-
Boston Medical CenterGunze LimitedWithdrawnAir Leak From LungUnited States
-
Shenzhen Lando Biomaterials Co., Ltd.Peking UniversityCompleted
-
University Hospital, Basel, SwitzerlandCompletedProlonged Air Leak | Postoperative Air LeakSwitzerland
-
Rambam Health Care CampusRecruitingBone Loss | Missing TeethIsrael
-
Tufts UniversityCompletedAlveolar Bone LossUnited States
-
University of Firenze and Siena, Napoli, ItalyCompletedOral Soft Tissue ConditionsItaly
-
Hadassah Medical OrganizationCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteUnknown
-
Aesculap AGCompletedPrimary Median LaparotomyGermany